| September 16-19, 2018 │ Brisbane, Australia Brisbane 2018 Congress, Top Science Down Under |
|||
|
|
|||
| yyyy-mm-dd | Type | Link | Title and Presenters |
|
|
|||
| 2018-9-17 | IATDMCT-Contributed Papers |  |
Quantification of metformin in human serum by hydrophilic interaction liquid chromatography – mass spectrometry Ahmed Abdalla |
|
|
|||
| 2018-9-19 | IATDMCT-Contributed Papers | |
Loss of control of HIV viremia with OTC weight-loss drugs: A call for caution? Dario Cattaneo |
|
|
|||
| 2018-9-18 | IATDMCT-Contributed papers | |
Association of fludarabine exposure and survival after allogeneic cell transplantation: Retrospectively estimated and prospectively simulated Erik van Maarseveen |
|
|
|||
| 2018-9-18 | IATDMCT-Contributed papers | |
Paracetamol use prior to HCT conditioning has a significant effect on the within-patient busulfan pharmacokinetics over time. Erik van Maarseveen |
|
|
|||
| 2018-9-18 | IATDMCT-Contributed Papers | |
Establishment of a national Therapeutic Drug Monitoring (TDM) service for the treatment of challenging childhood cancer patient populations Gareth Veal |
|
|
|||
| 2018-9-17 | IATDMCT-Contributed Papers | |
Detection of synthetic opioids using high resolution mass spectrometry: Keeping up with the trends Kara Lynch |
|
|
|||
| 2018-9-18 | IATDMCT-Contributed Papers | |
Clinical validation of a DPD functional test in dried saliva sample as predictor of 5-fluorouracil exposure and severe toxicity Marina Antunes |
|
|
|||
| 2018-9-18 | IATDMCT-Contributed Papers | |
The cost-effectiveness of Therapeutic Drug Monitoring (TDM) of generic imatinib for the treatment of Chronic Myelogenous Leukemia (CML) Salvatore Salamone |
|
|
|||
| 2018-9-19 | IATDMCT-Contributed Papers | |
Vancomycin – Improving prescribing practices Sophie Stocker |
|
|
|||
| 2018-9-17 | IATDMCT-Contributed Papers | |
Designer benzodiazepines pharmacological effects: how to find the information? Souleiman El Balkhi |
|
|
|||
| 2018-9-19 | IATDMCT-Contributed Papers | |
Development of ƒ%T>MIC calculation model and its application in individualized medication optimization of carbopenems in critical care patients Wenqian Chen |
|
|
|||
| 2018-9-17 | Symposium 3 | |
Determining unbound drug concentrations Brett McWhinney |
|
|
|||
| 2018-9-18 | Symposium 9 | |
Development of dosing support tools for paediatric diseases Catherine Knibbe |
|
|
|||
| 2018-9-18 | Symposium 9 | |
Evaluation and integration dosing tools in special populations Catherine Sherwin |
|
|
|||
| 2018-9-19 | Symposium 15 | |
How to detect Novel Psychoactive Substances in a clinical setting? Eric Franssen |
|
|
|||
| 2018-9-16 | Plenary Presentation | |
Clinical Toxinology – evidence to address the myths Geoff Isbister |
|
|
|||
| 2018-9-18 | Symposium 9 | |
Medicine dose-response(s) in children translated into algorithms: population vs individual Hesh Al-Sallami |
|
|
|||
| 2018-9-19 | Plenary Presentation | |
Tackling antibiotic resistance by targeting virulence not viability Jennifer Martin |
|
|
|||
| 2018-9-18 | Symposium 11 | |
Breast milk for the estimation of neonatal and lactational exposure to environmental pollutants Jochen Mueller |
|
|
|||
| 2018-9-17 | Symposium 7 | |
Dried blood spot; when will it become standard of care? Marieke G.G. Sturkenboom |
|
|
|||
| 2018-9-18 | Contributed papers | |
Regorafenib pharmacokinetics and exposure-toxicity relationship in Japanese cancer patients Masahide Fukudo |
|
|
|||
| 2018-9-17 | Symposium 3 | |
Protein binding and the interpretation of drug concentrations Matt Doogue |
|
|
|||
| 2018-9-19 | Contributed papers | |
The effectiveness and safety of individualized vancomycin dosing via pharmacokinetic monitoring in critically ill patients Na He |
|
|
|||
| 2018-9-17 | Symposium 7 | |
Patient Centric Blood Sampling – What is it and where might it be taking us? Neil Spooner |
|
|
|||
| 2018-9-18 | Symposium 11 | |
Adipose tissue as a site of environmental pollutants accumulation Nicolas Venisse |
|
|
|||
| 2018-9-17 | Symposium 3 | |
TDM and protein binding in critical care – flucloxacillin and phenytoin Paul Chin |
|
|
|||
| 2018-9-19 | Symposium 15 | |
Post mortem toxicology screening in a forensic setting Peter Zweipfenning |
|
|
|||
| 2018-9-18 | Symposium 9 | |
Application of decision support tools in hospitals Stefanie Hennig |
|
|
|||
| 2018-9-17 | Symposium 7 | |
Microsampling in critically ill patients Suzanne Parker |
|
|
|||
| 2018-9-19 | Symposium 15 | |
Novel psychoactive substances in the Netherlands and beyond: Challenges for clinical toxicology and pharmacology Sven van Dijkman on behalf of Tibor Brunt |
|
|
|||
IATDMCT, 4 Cataraqui Street Suite 310
Kingston, ON, K7K 1Z7, Canada
